Correlation Between OncoCyte Corp and Volitionrx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Volitionrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Volitionrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Volitionrx, you can compare the effects of market volatilities on OncoCyte Corp and Volitionrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Volitionrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Volitionrx.

Diversification Opportunities for OncoCyte Corp and Volitionrx

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between OncoCyte and Volitionrx is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Volitionrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Volitionrx and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Volitionrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Volitionrx has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Volitionrx go up and down completely randomly.

Pair Corralation between OncoCyte Corp and Volitionrx

Considering the 90-day investment horizon OncoCyte Corp is expected to under-perform the Volitionrx. But the stock apears to be less risky and, when comparing its historical volatility, OncoCyte Corp is 2.09 times less risky than Volitionrx. The stock trades about -0.26 of its potential returns per unit of risk. The Volitionrx is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  76.00  in Volitionrx on September 14, 2024 and sell it today you would lose (15.00) from holding Volitionrx or give up 19.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OncoCyte Corp  vs.  Volitionrx

 Performance 
       Timeline  
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Volitionrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Volitionrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Volitionrx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

OncoCyte Corp and Volitionrx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoCyte Corp and Volitionrx

The main advantage of trading using opposite OncoCyte Corp and Volitionrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Volitionrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Volitionrx will offset losses from the drop in Volitionrx's long position.
The idea behind OncoCyte Corp and Volitionrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation